Moderna Reports Positive Results From Early CCP Virus Vaccine Trial
A pharmacist gives Jennifer Haller the first shot in the first-stage safety study clinical trial of a potential vaccine for the CCP virus, at the Kaiser Permanente Washington Health Research Institute in Seattle on March 16, 2020. The vaccine was developed by Moderna. Ted S. Warren/AP Photo
Moderna on May 18 reported positive results from an early trial of its CCP virus vaccine.
The Massachusetts-based biotechnology company said that preliminary data from the trial showed that all 45 participants produced antibodies against the CCP virus.
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
